Long-term Outcome of Adenosine A2A Receptor Antagonist on Lower Urinary Tract Symptoms in Male Parkinson Disease Patients (vol 41, pg 98, 2018)

Kitta Takeya; Yabe Ichiro; Kanno Yukiko

首页> 外文期刊>Clinical neuropharmacology >Long-term Outcome of Adenosine A2A Receptor Antagonist on Lower Urinary Tract Symptoms in Male Parkinson Disease Patients (vol 41, pg 98, 2018)

【24h】

Long-term Outcome of Adenosine A2A Receptor Antagonist on Lower Urinary Tract Symptoms in Male Parkinson Disease Patients (vol 41, pg 98, 2018)

机译：腺苷A2A受体拮抗剂在雄性帕金森病患者中尿路症状的长期结果（Vol 41，PG 98,2018）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical neuropharmacology》 |2019年第1期|共1页
作者
Kitta Takeya; Yabe Ichiro; Kanno Yukiko;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词

相似文献

外文文献
中文文献
专利

1. Long-term Outcome of Adenosine A2A Receptor Antagonist on Lower Urinary Tract Symptoms in Male Parkinson Disease Patients (vol 41, pg 98, 2018) [J] . Kitta Takeya, Yabe Ichiro, Kanno Yukiko Clinical neuropharmacology . 2019,第1期

机译：腺苷A2A受体拮抗剂在雄性帕金森病患者中尿路症状的长期结果（Vol 41，PG 98,2018）
2. Long-term outcome of tamsulosin for patients with lower urinary tract symptoms according to the treatment response defined by lower urinary tract symptom outcomes score. [J] . Kang SG, Park CH, Kim DK, International journal of clinical practice . 2011,第6期

机译：根据下尿路症状预后评分定义的治疗反应，坦索罗辛对下尿路症状患者的长期预后。
3. Effectivness of selective adenosine A2A receptor antagonist istradefylline on the motor symptoms of Parkinson’s disease correlates with the intracortical inhibition revealed by transcranial magnetic stimulation [J] . N. Murase, Y. Masuda, T. Masaki, Journal of the Neurological Sciences: Official Bulletin of the World Federation of Neurology . 2017,第期

机译：选择性腺苷A2A受体拮抗剂在帕金森病的电机症状对帕金森病的症状的有效性与经颅磁刺激透露的内部抑制相关
4. Identification and Comparison of Protein Candidate Biomarkers from Lower Urinary Tract Symptoms (LUTS) in Mouse Models and Human Patients [C] . Tyler Greer, Anatoliy Nechyporenko, Ling Hao, ASMS Conference on Mass Spectrometry and Allied Topics . 2014

机译：小鼠模型和人类患者中尿路症状（LUTS）蛋白候选生物标志物的鉴定及比较
5. Adenosine receptor antagonists show promising results as an adjunctive treatment for Parkinson's disease. [D] . Vallance, Christopher S. 2007

机译：腺苷受体拮抗剂作为帕金森氏病的辅助治疗方法显示出令人鼓舞的结果。
6. Long-term Outcome of Adenosine A2A Receptor Antagonist on Lower Urinary Tract Symptoms in Male Parkinson Disease Patients: Erratum [O] . -1

机译：男性帕金森病患者下尿路症状的腺苷A2A受体拮抗剂的长期结果：勘误
7. Long-term Outcome of Adenosine A2A Receptor Antagonist on Lower Urinary Tract Symptoms in Male Parkinson Disease Patients: Erratum [O] . 2019

机译：腺苷A2A受体拮抗剂在雄性帕金森病患者中低尿路症状的长期结果：错误
8. Targeting Adenosine A2A Receptors in Parkinson's Disease [R] . Schwarzschild, M. A. 2006

机译：靶向帕金森病中的腺苷a2a受体

Long-term Outcome of Adenosine A2A Receptor Antagonist on Lower Urinary Tract Symptoms in Male Parkinson Disease Patients (vol 41, pg 98, 2018)

著录项

相似文献

相关主题

期刊订阅